It has been documented that CTGF is aberrantly expressed in human cancer, is linked to the promotion or inhibition of the carcinogenic process, and is produced by several types of stromal cells, including tumor endothelial cells, vascular smooth muscle cells, and cancer-associated fibroblasts [11, 21]. The gene discussed is CCN2; the disease is cancer.